M&A SECTOR SALUD

M&A SECTOR SALUD

Te acompañamos en cada paso
Array ( [0] => WP_Term Object ( [term_id] => 296 [name] => capital riesgo 2015 [slug] => capital-riesgo-2015 [term_group] => 0 [term_taxonomy_id] => 296 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 2 [filter] => raw ) [1] => WP_Term Object ( [term_id] => 654 [name] => m&a biotecnología [slug] => ma-biotecnologia [term_group] => 0 [term_taxonomy_id] => 654 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 2 [filter] => raw ) [2] => WP_Term Object ( [term_id] => 334 [name] => M&A españa [slug] => ma-espana [term_group] => 0 [term_taxonomy_id] => 334 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 129 [filter] => raw ) [3] => WP_Term Object ( [term_id] => 655 [name] => M&A SECTOR SALUD [slug] => ma-sector-salud [term_group] => 0 [term_taxonomy_id] => 655 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) )
Invent Pharma y Palex: M&A sector sanitario Junio 2016
Las firmas de capital riesgo están impulsando el sector sanitario en España. Este mes hemos conocido que Corpfin ha co [...]
seguir leyendo >>
closechevron-downcrossmenuchevron-down